Posted inGenetics
Posted inGenetics
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
Eli Lilly researchers at work. Lilly on Friday presented early positive clinical data supporting once-weekly dosing for its GIP/GLP-1 receptor…














